Literature DB >> 26618736

Characterization of a new Lactobacillus salivarius strain engineered to express IBV multi-epitope antigens by chromosomal integration.

Bing-cun Ma1, Xin Yang1, Hong-ning Wang1, Hai-peng Cao1, Peng-wei Xu1, Meng-die Ding1, Hui Liu1.   

Abstract

To obtain adhesive and safe lactic acid bacteria (LAB) strains for expressing heterologous antigens, we screened LAB inhabitants in intestine of Tibetan chickens by analyzing their adhesion and safety properties and the selected LAB was engineered to express heterologous antigen (UTEpi C-A) based on chromosomal integration strategy. We demonstrated that a new Lactobacillu salivarius TCMM17 strain is strongly adhesive to chicken intestinal epithelial cells, contains no endogenous plasmids, is susceptible to tested antimicrobials, and shows no toxicities. In order to examine the potential of TCMM17 strain as heterogenous antigen delivering vehicle, we introduced a UTEpi C-A expression cassette in its chromosome by constructing a non-replicative plasmid (pORI280-UUTEpi C-AD). The recombinant TCMM17 strain (∆TCMM17) stably was found to keep the gene cassette through 50 generations, and successfully displayed EpiC encoded by the cassette on its surface. This work provides a universal platform for development of novel oral vaccines and expression of further antigens of avian pathogens.

Entities:  

Keywords:  Lactobacillus salivarius; Tibetan chicken; chromosomal integration; thyA-deficient

Mesh:

Substances:

Year:  2015        PMID: 26618736     DOI: 10.1080/09168451.2015.1101330

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  2 in total

Review 1.  Harnessing the potential of Lactobacillus species for therapeutic delivery at the lumenal-mucosal interface.

Authors:  Joseph R Spangler; Julie C Caruana; Igor L Medintz; Scott A Walper
Journal:  Future Sci OA       Date:  2021-02-04

Review 2.  Lactobacillus Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens.

Authors:  Jonathan S LeCureux; Gregg A Dean
Journal:  mSphere       Date:  2018-05-16       Impact factor: 4.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.